Development of an enhanced formulation for delivering sustained release of buprenorphine hydrochloride

Saudi Pharmaceutical Journal

Volumn 19, Issue 4, 2011, Pages 255-262

  Koocheki, S ^a   Madaeni, S S ^a   Niroomandi, P ^b  

^a RAZI UNIVERSITY   (Iran)

^b Exir Pharmaceutical Co   (Iran)

Author keywords

Buprenorphine HCl; In situ forming implant; Membrane; PLGA; Tween 80

Indexed keywords

BUPRENORPHINE; POLYSORBATE 80;

ARTICLE; ARTIFICIAL MEMBRANE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; DRUG STRUCTURE; GLASS TRANSITION TEMPERATURE; IN SITU FORMING IMPLANT; MATHEMATICAL MODEL; MEMBRANE STRUCTURE; POROSITY; SCANNING ELECTRON MICROSCOPY; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION; X RAY DIFFRACTION;

EID: 80052921813     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2011.05.001     Document Type: Article

References (31)

1. Agnihotri S.M., Vavia P.R. Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application. Nanomedicine: NBM 2009, 5:90-95.
2. Atkins P.W. Physical Chemistry 1990, VHC VerlagsgesellschaftmbH, Weinheim. second ed.
3. Basak S.C., Kumar K.S., Ramalingam M. Design and release characteristics of sustained release tablet containing metformin HCl. Braz. J. Pharm. Sci. 2008, 44:477-483.
4. Blasi P., Souza S., Selmin F., Deluca P. Plasticizing effect of water on poly(lactide-co-glycolide). J. Control. Release 2005, 108:1-9.
5. Brodbeck K.J., DesNoyer J.R., McHugh A.J. Phase inversion dynamics of PLGA solutions related to drug delivery: Part II. The role of solution thermodynamics and bath-side mass transfer. J. Control. Release 1999, 62:333-344.
6. Dunn, R.L., English, P., Vanderbilt, P., 1990. Biodegradable in-situ forming implants and methods of producing the same [14,938,763]. Patent 4938763.
7. Fox C.B. Squalene emulsions for parenteral vaccine and drug delivery. Molecules 2009, 14:3286-3312.
8. Graves R.A., Freeman T., Mandal T.K. In vitro dissolution method for evaluation of buprenorphine in situ gel formulation: a technical note. AAPS Pharm. Sci. Technol. 2007, 8. Article 62.
9. Himanshu G., Mohammed A., Roop K., Asgar A., Aseem B., Gaurav M. Parfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery. Nanomedicine: Nanotechnol. Biol. Med. 2010, 6:324-333.
10. Hutchings D.E., Zmitrovich A.C., Hamowy A.S., Liu P.V. Prenatal administration of buprenorphine using the osmotic minipump: a preliminary study of maternal and offspring toxicity and growth in the rat. Neurotoxicol. Teratol. 2007, 17:419-423.
11. Johnson R.E., Fudala P.J., Payne R. Buprenorphine: considerations for pain management. J. Pain Symptom Manage. 2005, 29:297-326.
12. Kempe S., Metz H., Mader K. Do in situ forming PLG/NMP implants behave similar in vitro and in vivo? A non-invasive and quantitative EPR investigation on the mechanisms of the implant formation process. J. Control. Release 2008, 130:220-225.
13. Liu S.J., Kau Y.C., Chou C.Y., Chen J.K., Wu R.C., Yeh W.L. Electrospun PLGA/collagen nanofibrous membrane as early-stage wound dressing. J. Membr. Sci. 2010, 355:53-59.
14. Loeb S., Sourirajan S. Sea water demineralization by means of an osmotic membrane. Adv. Chem. Ser. 1963, 38:117.
15. Luan X., Bodmeier R. Influence of the poly(lactide-co-glycolide) type on the leuprolide release from in situ forming microparticle systems. J. Control. Release 2006, 110:266-272.
16. Mohamadnia Z., Ahmadi E., Rafienia M., Mirzadeh H., Mobedi H. Investigation of drug release and 1H-NMR analysis of the in situ forming systems based on poly(lactide-co-glycolide. Polym. Adv. Technol. 2009, 20:48-57.
17. Ofokansi K.C., Chukwu K.I., Ugwuany S.I. The use of liquid self-microemulsifying drug delivery systems based on peanut oil/Tween 80 in the delivery of griseofulvin. Drug Dev. Ind. Pharm. 2009, 35:185-191.
18. Packhaeuser C.B., Schnieders J., Oster C.G., Kissel T. In situ forming parenteral drug delivery systems: an overview. Eur. J. Pharm. Biopharm. 2004, 58:445-455.
19. Patel A.R., Vavia R. Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate. AAPS J. 2007, 9:344-352.
20. Pignatello R., Bucolo C., Maltese P., Puleo A., Puglisi G. Eudragit RS100® nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur. J. Pharm. Sci. 2002, 16:53-61.
21. Rafienia M., Hojjati Emami S., Mirzadeh H., Mobedi H., Karbasi S. Influence of poly (lactide-co-glycolide) type and gamma irradiation on the betamethasone acetate release from the in situ forming systems. Curr. Drug Deliv. 2009, 6:184-191.
22. Ravivarapu H.B., Moyer K.L., Dunn R.L. Sustained suppression of pituitary-gonadal axis with an injectable, in situ forming implant of leuprolide acetate. J. Pharm. Sci. 2000, 89:732-741.
23. Sakr W., Alanazi F., Sakr A. Effect of Kollidon SR on the release of Albuterol Sulphate from matrix tablets. Saudi Pharm. J. 2011, 19:19-27.
24. Schuh K.J., Johanson C.E. Pharmacokinetic comparison of the buprenorphine sublingual liquid and tablet. Drug Alcohol Depend. 1999, 56:55-60.
25. Shoaib M.H., Tazeen J., Merchant H.A., Ismail Yousuf R. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC. Pak. J. Pharm. Sci. 2006, 19:119-124.
26. Singhal A., Tripathi B.M., Pal H.R., Jena R., Jain R. Subjective effects of additional doses of buprenorphine in patients on buprenorphine maintenance. Addict. Behav. 2007, 32:320-331.
27. Stamatialis D.F., Papenburg B.J., Girones M., Saiful S., Bettahalli S.N.M., Schmitmeier S., Wessling M. Medical applications of membranes: drug delivery, artificial organs and tissue engineering. J. Membr. Sci. 2008, 308:1-34.
28. Wang J.J., Liu K.S., Sung K.C., Tsai C.Y., Fang J.Y. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection. Eur. J. Pharm. Sci. 2009, 38:138-146.
29. Wang L., Dong J., Chen J., Eastoe J., Li X. Design and optimization of a new self-nanoemulsifying drug delivery system. J. Colloid Interface Sci. 2009, 330:443-448.
30. Wilding I.R., Davis S.S., Rimoy G.H., Rubin P., Kurihara-Bergstrom T., Tipnis V., Berner B., Nightingale J. Pharmacokinetic evaluation of transdermal buprenorphine in man. Int. J. Pharm. 1996, 132:81-87.
31. Young T.H., Chuang W.Y., Wei C.W., Tang C.Y. Investigation of the drug distribution and release characteristics from particulate membranes. J. Membr. Sci. 2001, 191:199-205.